Sign in
Back
Aortic valve replacement in a patient with sickle cell disease-Are we justified to perform surgery in the TAVI era?
Journal article   Peer reviewed

Aortic valve replacement in a patient with sickle cell disease-Are we justified to perform surgery in the TAVI era?

Ramanish Ravishankar, Leenah Turkistani, Yasser Elghoneimy and Imthiaz Manoly
Clinical case reports, Vol.9(8)
01/08/2021
DOI: https://doi.org/10.1002/ccr3.4085
PMID: 34471536

Abstract

General & Internal Medicine Life Sciences & Biomedicine Medicine, General & Internal Science & Technology
Not all variants of SCD need the same management and this should be decided on a case-by-case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.

Metrics

1 Record Views

Details